FDA — authorised 13 May 2005
- Application: BLA103964
- Marketing authorisation holder: Pharmaand GmbH
- Indication: Labeling
- Status: approved
🇺🇸 Peginterferon in United States
FDA authorised Peginterferon on 13 May 2005
Marketing authorisations
FDA — authorised 22 December 2015
- Application: BLA125499
- Marketing authorisation holder: BIOGEN IDEC INC
- Indication: Labeling
- Status: approved
Peginterferon in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Peginterferon approved in United States?
Yes. FDA authorised it on 13 May 2005; FDA authorised it on 22 December 2015.
Who is the marketing authorisation holder for Peginterferon in United States?
Pharmaand GmbH holds the US marketing authorisation.